Posts in Uncategorized

Document Control in a Pharmaceutical QMS: Hierarchy, Versions and the Draft EU Chapter 4

Documentation is the evidence base of a quality system, and a revised EU GMP Chapter 4 proposed in 2025 puts data governance at the heart[…]

Responding to Inspection Findings: Structure, Tone and Timing of the Reply

The inspection ends when the inspectors leave the site, but the outcome is often decided by the quality of the written response that follows. Know[…]

Supplier Qualification in Pharma: Risk-Based Vendor Audits That Hold Up

Regulators hold the marketing authorisation holder or manufacturer responsible for outsourced activities, so supplier qualification is a core compliance control, not an administrative formality. Why[…]

Tracking Post-Approval Commitments: Keeping Conditions and Obligations From Slipping

A marketing authorisation is not the end of regulatory work. It carries conditions, commitments and deadlines that, if missed, can lead to enforcement and, in[…]

Regulatory Intelligence: Building a Process That Catches Changes Before They Catch You

Most compliance failures start with a change nobody noticed: a new guideline, a revised template, an amended national requirement. Regulatory intelligence is the process that[…]

Periodic Review and Retirement of Validated Systems: The Back End of the Lifecycle

A system is not validated forever. Periodic review confirms it still does what it was validated to do, and retirement makes sure the data it[…]

Validating Spreadsheets Used in GxP Work: Controls for the Tool Everyone Uses

Spreadsheets remain the most widely used and least controlled computerised tool in regulated companies, and inspectors know exactly where to look for the weaknesses. Why[…]

GAMP 5 Software Categories: Matching Validation Effort to What You Bought

GAMP 5 categorises software by how much it is configured or customised, and that simple idea is the fastest way to decide how much validation[…]

Writing a User Requirements Specification That Validation Can Actually Test

Most weak validation packages trace back to a weak user requirements specification (URS): a document that describes a wish list, not testable requirements tied to[…]

Veterinary Clinical Trials and VICH GL9: Getting the Efficacy Part Right

The efficacy part of a veterinary dossier stands or falls on clinical trials that were designed for the claim and conducted to Good Clinical Practice,[…]

1 … 16 17 18 19 20 … 26